September 1, 2017 / 8:22 PM / a year ago

BRIEF-Cytori announces corporate restructuring & cost reduction plan

Sept 1 (Reuters) - Cytori Therapeutics Inc

* Cytori announces corporate restructuring & cost reduction plan

* Cytori announces corporate restructuring & cost reduction plan

* Cytori Therapeutics Inc - ‍restructuring is expected to reduce Cytori’s workforce by approximately 50% and significantly reduce quarterly operational cash burn​

* Cytori Therapeutics - habeo program for scleroderma is expected to move forward based on feedback from forthcoming meetings with FDA in U.S., PMDA in Japan​

* Cytori Therapeutics Inc - ‍company and its advisors, tap advisors, will consider a range of options including a sale of company and a reverse merger​

* Cytori Therapeutics Inc - ‍announced a substantial corporate restructuring intended to significantly reduce expenses​

* Cytori Therapeutics Inc says ‍have engaged tap advisors to “help us evaluate several potential opportunities company has​”

* Cytori Therapeutics - ‍restructuring while maintaining ability to execute on its BARDA-sponsored cell therapy program, japanese business, oncology program​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below